QQ客服 官方微博 反馈留言

	Pleural MAC30 as a prognostic marker in NSCLC with malignant pleural effusion
	Shan, Yi[1]; Ding, Hui[2]; Lu, Junjie[3]; Ge, Zhijun[4]; Tan, Yongfei[5]
刊名	ONCOTARGET
	2017
卷号	8期号:68页码:112809-112815
关键词	MAC30 MPE NSCLC BPE OS
ISSN号	1949-2553
DOI	http://dx.doi.org/10.18632/oncotarget.22631
URL标识	查看原文
收录类别	SCI(E)
WOS记录号	WOS:000419569800054
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5342844
专题	江苏大学
作者单位	1.[1]Jiangsu Univ, Affiliated Yixing Hosp, Dept Crit Care Med, Yixing 214200, Jiangsu, Peoples R China. 2.[2]Jiangsu Univ, Affiliated Yixing Hosp, Dept Resp, Yixing 214200, Jiangsu, Peoples R China. 3.[3]Jiangsu Univ, Affiliated Yixing Hosp, Dept Crit Care Med, Yixing 214200, Jiangsu, Peoples R China. 4.[4]Jiangsu Univ, Affiliated Yixing Hosp, Dept Crit Care Med, Yixing 214200, Jiangsu, Peoples R China. 5.[5]Jiangsu Univ, Affiliated Yixing Hosp, Dept Cardiac & Thorac Surg, Yixing 214200, Jiangsu, Peoples R China.
推荐引用方式 GB/T 7714	Shan, Yi[1],Ding, Hui[2],Lu, Junjie[3],et al. Pleural MAC30 as a prognostic marker in NSCLC with malignant pleural effusion[J]. ONCOTARGET,2017,8(68):112809-112815.
APA	Shan, Yi[1],Ding, Hui[2],Lu, Junjie[3],Ge, Zhijun[4],&Tan, Yongfei[5].(2017).Pleural MAC30 as a prognostic marker in NSCLC with malignant pleural effusion.ONCOTARGET,8(68),112809-112815.
MLA	Shan, Yi[1],et al."Pleural MAC30 as a prognostic marker in NSCLC with malignant pleural effusion".ONCOTARGET 8.68(2017):112809-112815.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。